ArticleCancer research2021

Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.

Atreyi Dasgupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.